Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof | Patent Number 08685934

US 08685934 B2
Application Number13321103
Publication NumberUS 20120071403 A1
Pendency3 years, 10 months, 11 days
Filled DateMay 26, 2010
Priority DateMay 27, 2009
Publication DateMar 22, 2012
Expiration DateMay 26, 2029
Inventor/ApplicantsJames List
Stephanie Moran
Paul Strumph
ExaminesWEDDINGTON, KEVIN E
Art Unit1629
Technology Center1600
Assignments
Astrazeneca
Current
Bristol Myers Squibb
Original
Astrazeneca
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.